MedPath

Effect of Hapushadi Yapan Basti and Kokilaksha Ksheerbasti in Vatrakta (~Gout) â?? Randomized control trial

Phase 2
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2023/07/055056
Lead Sponsor
DMIMS MGACH RC Salod Wardha Maharashtra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient showing signs and symptoms of vatarakta (gouty arthritis)

Age group between 20 to 70 years

Patient willing for written consent

Patient indicated for basti

Patient with elevated uric acid level

Exclusion Criteria

Patients diagnosed with any other systemic illness which are fatal and chronic in nature

Below 20 and above 70 years old patients

Known case of ulcers or ulcerativecolitis

Basti Ayogy(patient unfit for Basti chikitsa)

Pregnant woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum uric acid <br/ ><br> sign and symptoms of VatarakataTimepoint: 24 days with followup baseline and on 8th & 24th day
Secondary Outcome Measures
NameTimeMethod
Sandhishoola (Pain in joints), <br/ ><br>. Sparshasahatva (Tenderness of joints) , <br/ ><br> Sandhidaha (Burning sensation in joints), <br/ ><br> Sandhigraha (stiffness in joints). <br/ ><br> Angavaikalya (Deformity of joints) <br/ ><br> <br/ ><br> Sr. uric acid <br/ ><br>Sandhishotha (joint circumference for assess swelling). <br/ ><br>Timepoint: 24 days with follow up basline and on 8th & 21th day
© Copyright 2025. All Rights Reserved by MedPath